Lantus Solostar

Lantus Solostar

insulin glargine

Manufacturer:

sanofi-aventis

Distributor:

DKSH
Concise Prescribing Info
Contents
Insulin glargine
Indications/Uses
Once daily SC administration for DM in adults, adolescents & childn ≥2 yr.
Dosage/Direction for Use
Individualised dosage. May be administered once daily at any time of the day, however, at the same time everyday.
Special Precautions
Transferring to other type or brand of insulin. Hypoglycaemia. Intercurrent illness. Check insulin label before each inj to avoid medication error. May affect ability to drive & operate machinery.
Adverse Reactions
Hypoglycaemia, lipohypertrophy, inj site reactions.
Drug Interactions
Enhanced effects by oral antidiabetics, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAOIs, pentoxifylline, propoxyphene, salicylates, sulfonamide antibiotics. Reduced effects by corticosteroids, danazol, diazoxide, diuretics, glucagon, INH, oestrogens & progestogens, phenothiazine derivatives, somatropin, sympathomimetics, thyroid hormones, atypical antipsychotics, PIs. Potentiated or weakened insulin effects by β-blockers, clonidine, lithium salts or alcohol. Hypoglycaemia followed by hyperglycaemia w/ pentamidine. Reduced or offset signs of adrenergic counterregulation by sympatholytics.
ATC Classification
A10AE04 - insulin glargine ; Belongs to the class of long-acting insulins and analogues for injection. Used in the treatment of diabetes.
Presentation/Packing
Form
Lantus Solostar soln for inj (pre-filled pen) 100 U/mL
Packing/Price
3 mL x 5 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in